309 related articles for article (PubMed ID: 34717608)
1. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study.
Pinheiro C; Costa T; Amorim de Jesus R; Campos R; Brim R; Teles A; Vilas Boas A; Lordêlo P
BMC Womens Health; 2021 Oct; 21(1):379. PubMed ID: 34717608
[TBL] [Abstract][Full Text] [Related]
2. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
3. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
4. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
[TBL] [Abstract][Full Text] [Related]
5. Microablative fractional radiofrequency for the genitourinary syndrome of menopause: protocol of randomised controlled trial.
Sarmento ACA; Fernandes FS; Costa APF; Medeiros KS; Crispim JC; Gonçalves AK
BMJ Open; 2021 Jul; 11(7):e046372. PubMed ID: 34226218
[TBL] [Abstract][Full Text] [Related]
6. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Cervigni M
Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of non-ablative CO
Lami A; Alvisi S; Baldassarre M; Zanella S; Amati V; Seracchioli R; Meriggiola MC
Arch Gynecol Obstet; 2024 Apr; 309(4):1575-1583. PubMed ID: 38253692
[TBL] [Abstract][Full Text] [Related]
8. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
[TBL] [Abstract][Full Text] [Related]
9. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: A single-arm feasibility study.
Mercier J; Morin M; Zaki D; Reichetzer B; Lemieux MC; Khalifé S; Dumoulin C
Maturitas; 2019 Jul; 125():57-62. PubMed ID: 31133219
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial.
Gueldini de Moraes AV; Costa-Paiva L; da Costa Machado H; Maciel TF; Mariano FV; Pedro AO
Menopause; 2024 Apr; 31(4):288-302. PubMed ID: 38412393
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a device that combines multipolar radiofrequency with pulsed electromagnetic field for the treatment of vulvovaginal atrophy: a randomized, sham-controlled trial.
Nappi RE; Martella S; Tiranini L; Cucinella L; Palacios S
J Sex Med; 2024 Feb; 21(3):203-210. PubMed ID: 38286753
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause.
Barba M; Cola A; De Vicari D; Costa C; Castelli AP; Volontè S; Fruscio R; Frigerio M
Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892888
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Genitourinary Syndrome of Menopause and 3D High-Frequency Endovaginal Ultrasound Measurement of Vaginal Wall Thickness.
Peker H; Gursoy A
J Sex Med; 2021 Jul; 18(7):1230-1235. PubMed ID: 34193368
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial: treatment of genitourinary syndrome of menopause using radiofrequency.
Joris A; Di Pietrantonio V; Praet J; Renard K; Verduyn AC; Buxant F; Rozenberg S
Climacteric; 2024 Apr; 27(2):210-214. PubMed ID: 38251861
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency.
Kamilos MF; Borrelli CL
Einstein (Sao Paulo); 2017; 15(4):445-451. PubMed ID: 29364367
[TBL] [Abstract][Full Text] [Related]
18. Microablative fractional CO
Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
